Gene · 6518
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GLUT5-Mediated Disruption of the Gut-Testis Axis Deteriorates Olanzapine-Induced Testicular Fibrosis and is Ameliorated by Dapagliflozin. | Drug Des Devel Ther | 2026 | 42787161 | PubTator, text mining | PubMed |
| Fructose induces PERK-dependent ER stress and mitochondrial dysfunction via nucleotide depletion in clear cell renal cell carcinoma. | Cell Death Dis | 2026 | 42675041 | PubTator, text mining | PubMed |
| Microbiota-Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma. | Brain Behav | 2026 | 42553012 | PubTator, text mining | PubMed |
| The brain's sweet spot: why microglia can run on fructose metabolism. | Front Immunol | 2026 | 42519336 | PubTator, text mining | PubMed |
| Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS Lymphoma. | Adv Sci (Weinh) | 2026 | 42360090 | PubTator, text mining | PubMed |
| β-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A. | Diabetes | 2026 | 42330303 | PubTator, text mining | PubMed |
| Differential expression patterns of selective energy metabolism associated genes in fresh and freeze-thawed bubaline spermatozoa at uniform durations of in vitro capacitation. | Cryobiology | 2026 | 42308645 | PubTator, text mining | PubMed |
| Fructose-Based Single-Chain Polymer Nanoparticles for GLUT1-Mediated Delivery: Impact of Polymer Design on Uptake and In Vivo Performance. | Adv Healthc Mater | 2026 | 42277625 | PubTator, text mining | PubMed |
| High-dimensional Spatial Immune Profiling Highlights Microglia-Like Cells in Human Dorsal Root Ganglia. | Eur J Immunol | 2026 | 42153599 | PubTator, text mining | PubMed |
| Fructose metabolism as an adaptive survival axis in pancreatic cancer: mechanistic insights and therapeutic implications. | Front Med (Lausanne) | 2026 | 42089053 | PubTator, text mining | PubMed |
| Preventive Effect of Butyrate in Colon Cancer Cell Metabolism. | Int J Mol Sci | 2026 | 42074334 | PubTator, text mining | PubMed |
| The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway. | Sci Rep | 2026 | 41896383 | PubTator, text mining | PubMed |
| Molecular mechanisms of NLRP3 inflammasome activation. | Exp Mol Med | 2026 | 41876821 | PubTator, text mining | PubMed |
| Identification of hypoxia-related gene signatures and molecular subtypes in chronic rhinosinusitis with nasal polyps. | Braz J Otorhinolaryngol | 2026 | 41855680 | PubTator, text mining | PubMed |
| Quantification of Monosaccharides in Blood and Urine by HPAEC-PAD. | J Agric Food Chem | 2026 | 41831234 | PubTator, text mining | PubMed |
| Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation. | Ann Med | 2026 | 41800605 | PubTator, text mining | PubMed |
| Toxicological Assessment of D-Allulose From a Novel One-Step Fermentation Process Using Genetically Modified Escherichia coli: A 90-Day Dietary Toxicity Study in Rats. | J Toxicol | 2026 | 41788188 | PubTator, text mining | PubMed |
| GLUT5-Driven Gut-Liver Axis Injury Mediating Olanzapine-Induced NAFLD and Dapagliflozin Intervention. | Drug Des Devel Ther | 2026 | 41783576 | PubTator, text mining | PubMed |
| Unraveling the αVβ5-GLUT5 axis in breast cancer: linking extracellular matrix signaling to fructose metabolism: a scoping review. | Mol Biol Rep | 2026 | 41774272 | PubTator, text mining | PubMed |
| Impact of sodium alginate energy gel on the marathon performance of amateur runners: a randomized controlled study. | Front Physiol | 2026 | 41755891 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6518/papers